Vital Farms director buys 2,500 shares

Vital Farms, Inc. director Kelly J. Kennedy reported an open-market purchase of Common Stock.

Rhea-AI Filing Summary

Vital Farms, Inc. director Kelly J. Kennedy reported an open-market purchase of Common Stock. On May 14, 2026, Kennedy bought 2,500 shares at a weighted average price of $8.40 per share, with individual trades executed between $8.28 and $8.40. Following this transaction, Kennedy directly owns 22,927 shares of Vital Farms common stock, indicating a modest increase in personal investment in the company.

Insider Trade Summary

Net Buyer: 2,500 shares

Net Buy 1 txn

Insider Kennedy Kelly J.

Role Director

Bought 2,500 shs ($21K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	2,500	$8.40	$21K

Holdings After Transaction: Common Stock — 22,927 shares (Direct)

Footnotes (1)

1. F1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.28 to $8.40 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Key Figures

Shares purchased: 2,500 shares Weighted average price: $8.40 per share Price range: $8.28–$8.40 per share +1 more

4 metrics

Shares purchased 2,500 shares Open-market purchase on May 14, 2026

Weighted average price $8.40 per share Average purchase price for 2,500 shares

Price range $8.28–$8.40 per share Range of prices for multiple trades

Shares owned after 22,927 shares Direct ownership following the transaction

Key Terms

open-market purchase, weighted average price, Common Stock

3 terms

open-market purchase financial

"Kennedy bought 2,500 shares of its Common Stock in an open-market transaction."

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Common Stock financial

"Kennedy bought 2,500 shares of its Common Stock in an open-market transaction."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Vital Farms (VITL) disclose for Kelly J. Kennedy?

Vital Farms reported that director Kelly J. Kennedy purchased 2,500 shares of its Common Stock in an open-market transaction. This Form 4/A filing reflects a personal investment increase rather than a sale or option exercise, and it updates Kennedy’s direct ownership position.

At what price did Kelly J. Kennedy buy Vital Farms (VITL) shares?

Kennedy’s purchase has a weighted average price of $8.40 per share. According to the disclosure, the shares were bought in multiple trades at prices ranging from $8.28 to $8.40, and full trade details are available upon request from the company or regulators.

How many Vital Farms (VITL) shares does Kelly J. Kennedy own after this transaction?

After buying 2,500 shares, Kennedy directly owns 22,927 shares of Vital Farms Common Stock. This updated holding figure comes from the Form 4/A and reflects only the position reported in this filing, not any separate derivative or indirect interests.

What does a weighted average purchase price mean in this Vital Farms (VITL) filing?

The weighted average price of $8.40 means shares were bought at several prices between $8.28 and $8.40. The average is calculated across all trade sizes and prices, and the insider has committed to provide detailed per-trade pricing information upon request.

Is this Vital Farms (VITL) Form 4/A transaction an open-market purchase or option exercise?

The transaction is classified as an open-market purchase of Common Stock, not an option exercise or derivative conversion. The filing shows no accompanying derivative transactions, and the derivative holdings section in this report is empty.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/21/2026 - 04:55 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kennedy Kelly J.

(Last) (First) (Middle)

C/O VITAL FARMS, INC.

3601 SOUTH CONGRESS AVENUE, SUITE A100

(Street)

AUSTIN TEXAS 78704

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vital Farms, Inc. [ VITL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
05/18/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/14/2026		P		2,500	A	$8.4(1)	22,927	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.28 to $8.40 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Remarks:

This Form 4/A amends the Form 4 filing dated May 18, 2026, solely to amend the footnote in this report to clarify that the transaction referred to in Table I was a purchase.

	/s/ Francis Cullo, Attorney-in-Fact	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)